---
figid: PMC6487485__nihms-1504061-f0001
figlink: /pmc/articles/PMC149053/figure/fig7/
number: ''
caption: 'Regulation of bile acid synthesis by feedback mechanism and bile acid transport
  through enterohepatic circulation. In the liver the bile acids (CDCA, DCA, LCA,
  CA) activate FXR that inhibits (via a repressor SHP, not shown here) the rate-limiting
  enzyme CYP7A1. The bile acids via FXR/SHP also inhibit the influx transporter NTCP;
  induce BSEP and canalicular bile acid secretion. In the intestine, bile acids, via
  FXR, inhibit the uptake transporter ASBT, decreasing absorption and increasing basolateral
  secretion into portal circulation by inducing OSTα & β. Bile acid activated FXR
  in the intestine also exerts inhibition on CYP7A1 in the liver via FGF19 pathway.
  At the basolateral membrane of hepatocytes, transporters OSTα & β, and also MRP3
  and MRP4, secrete bile acids into the systemic circulation.Abbreviations: ASBT:
  Apical Sodium-dependent Bile acid Transporters; BSEP: Bile Salt Export Pump; FXR:
  Farnesoid X Receptor; NTCP: Sodium/Taurocholate Co-transporting Polypeptide; SHP:
  Small heterodimer partner.'
pmcid: PMC6487485
papertitle: Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s
  Disease – An Emerging Role for Gut Microbiome.
reftext: Siamak MahmoudianDehkordi, et al. Alzheimers Dement. 2019 Jan;15(1):76-92.
pmc_ranked_result_index: '32698'
pathway_score: 0.9062436
filename: nihms-1504061-f0001.jpg
figtitle: Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s
  Disease – An Emerging Role for Gut Microbiome
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6487485__nihms-1504061-f0001.html
  '@type': Dataset
  description: 'Regulation of bile acid synthesis by feedback mechanism and bile acid
    transport through enterohepatic circulation. In the liver the bile acids (CDCA,
    DCA, LCA, CA) activate FXR that inhibits (via a repressor SHP, not shown here)
    the rate-limiting enzyme CYP7A1. The bile acids via FXR/SHP also inhibit the influx
    transporter NTCP; induce BSEP and canalicular bile acid secretion. In the intestine,
    bile acids, via FXR, inhibit the uptake transporter ASBT, decreasing absorption
    and increasing basolateral secretion into portal circulation by inducing OSTα
    & β. Bile acid activated FXR in the intestine also exerts inhibition on CYP7A1
    in the liver via FGF19 pathway. At the basolateral membrane of hepatocytes, transporters
    OSTα & β, and also MRP3 and MRP4, secrete bile acids into the systemic circulation.Abbreviations:
    ASBT: Apical Sodium-dependent Bile acid Transporters; BSEP: Bile Salt Export Pump;
    FXR: Farnesoid X Receptor; NTCP: Sodium/Taurocholate Co-transporting Polypeptide;
    SHP: Small heterodimer partner.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GUCY2D
  - CYP8B1
  - NR4A3
  - CYP27A1
  - HSD3B7
  - GCA
  - GNAT3
  - bile acid
  - Cholesterol
  - Bile Acids
  - hydroxycholesterol
  - hydroxyl-4-cholesten-3-one
  - 7a-dihydroxy-5-cholestenoic acid
  - CDCA
  - Bile acid
  - CoA
  - amino acid
  - 'N'
  - TCA
  - GCDCA TCDCA
  - DCA
  - UDCA
  - bile acids
  - TUDCA
  - GUDCA TLCA
  - TDCA
  - ti GDCA
  - AD
  - Cytotoxic
genes:
- word: LCA
  symbol: LCA
  source: hgnc_prev_symbol
  hgnc_symbol: GUCY2D
  entrez: '3000'
- word: CYP8B1
  symbol: CYP8B1
  source: hgnc_symbol
  hgnc_symbol: CYP8B1
  entrez: '1582'
- word: (Minor
  symbol: MINOR
  source: hgnc_alias_symbol
  hgnc_symbol: NR4A3
  entrez: '8013'
- word: '|CYP27A1'
  symbol: CYP27A1
  source: hgnc_symbol
  hgnc_symbol: CYP27A1
  entrez: '1593'
- word: HSD3B7
  symbol: HSD3B7
  source: hgnc_symbol
  hgnc_symbol: HSD3B7
  entrez: '80270'
- word: GCA
  symbol: GCA
  source: hgnc_symbol
  hgnc_symbol: GCA
  entrez: '25801'
- word: GDCA
  symbol: GDCA
  source: hgnc_alias_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
chemicals:
- word: bile acid
  source: MESH
  identifier: D001647
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Bile Acids
  source: MESH
  identifier: D001647
- word: hydroxycholesterol
  source: MESH
  identifier: D006888
- word: hydroxyl-4-cholesten-3-one
  source: MESH
  identifier: C000475
- word: 7a-dihydroxy-5-cholestenoic acid
  source: MESH
  identifier: C063075
- word: CDCA
  source: MESH
  identifier: C081330
- word: Bile acid
  source: MESH
  identifier: D001647
- word: CoA
  source: MESH
  identifier: C065987
- word: amino acid
  source: MESH
  identifier: D000596
- word: 'N'
  source: MESH
  identifier: D009584
- word: TCA
  source: MESH
  identifier: C000589078
- word: GCDCA TCDCA
  source: ''
  identifier: ''
- word: DCA
  source: MESH
  identifier: C048628
- word: UDCA
  source: MESH
  identifier: C433771
- word: bile acids
  source: MESH
  identifier: D001647
- word: TUDCA
  source: MESH
  identifier: C031655
- word: GUDCA TLCA
  source: ''
  identifier: ''
- word: TDCA
  source: MESH
  identifier: C083678
- word: ti GDCA
  source: MESH
  identifier: D014025
diseases:
- word: AD
  source: MESH
  identifier: D000544
- word: Cytotoxic
  source: MESH
  identifier: D064420
---
